Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
Current Treatment Options in Cardiovascular Medicine|September 26, 2008
New developments in anticoagulation for atrial fibrillationM Haris U Usman, Lawrence A Notaro, Harsh Patel, et al.
International Journal of Cardiology|October 9, 2015
Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and proceduresPhilip L Mar, Dmitry Familtsev, Michael D Ezekowitz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2002
Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid loweringRoberta Baetta, Marina Camera, Carmen Comparato, et al.
American Heart Journal|November 14, 2017
The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) studyGregory Y H Lip, Naab Al-Saady, Michael D Ezekowitz, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 8, 2015
Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in Asian RE-LY Patients According to Baseline Renal Function or CHADS2 ScoreMasatsugu Hori, Taku Fukaya, Eva Kleine, et al.
Circulation|February 6, 2002
Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP studyLouis D Fiore, Michael D Ezekowitz, Mary T Brophy, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 26, 2011
Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation--sub-analysis in Japanese population in RE-LY trialMasatsugu Hori, Stuart J Connolly, Michael D Ezekowitz, et al.
Gender Medicine|July 20, 2010
Gender in atrial fibrillation: Ten years laterHector I Michelena, Brian D Powell, Peter A Brady, et al.
Circulation|September 10, 2009
The first evaluation of a novel vitamin K antagonist, tecarfarin (ATI-5923), in patients with atrial fibrillationDavid J Ellis, Mohammed Haris Usman, Peter G Milner, et al.
Cardiovascular Therapeutics|August 20, 2009
Secondary prevention in concurrent coronary artery, cerebrovascular, and chronic kidney disease: focus on pharmacological therapyLawrence A Notaro, Mohammed H Usman, James F Burke, et al.
Pageof 15